News

March 12, 2024- PRESS RELEASE

Emboline Announces That the First One Hundred Patients Have Been Treated in the IDE Study of the Emboliner® Full-Body Embolic Protection Catheter to Minimize Stroke Risk From TAVR

October 26, 2023- ABSTRACT

Vora, A. (2023 Oct 23-26) Update from the PROTECT H2H Trial with Emboliner (Case Example). TCT 2023 San Francisco, CA USA.

September 16, 2023- ARTICLE

Grubman D, Ahmad Y, Leipsic JA, Blanke P, Pasupati S, Webster M, Nazif TM, Parise H, Lansky AJ (2023). Predictors of Cerebral Embolic Debris During Transcatheter Aortic Valve Replacement: The SafePass 2 First-in-Human Study. Am J Cardiol. 2023 Nov 15;207:28-34. doi: 10.1016/j.amjcard.2023.08.137. Epub 2023 Sep 16. PMID: 37722198.

June 29, 2023- ABSTRACT

Greenbaum, A (2023 Jun28-Jul1) Multi-generational Performance of the Emboliner Full-Body Embolic Protection Catheter for TAVI: the Complete SafePass Experience. CSI-Frankfurt 2023 Frankfurt, Germany.

June 9, 2023- ABSTRACT

Nazif, T. (2023 Jun 7-10) Performance of the New Generation Emboliner Embolic Protection Device for TAVI: the SafePass 3 Study. TVT2023 Phoenix, AZ USA.

May 19, 2023- ABSTRACT

Lansky, A. (2023 May 18-20) Full-Body Embolic Protection During Transcatheter Aortic Valve Replacement: the Protect the Head to Head Study- A Pivotal, Randomized Study Comparing the Emboliner Embolic Protection Catheter to the Sentinel CPS. SCAI 2023, Phoenix, AZ USA.

May 19, 2023- ABSTRACT

Abizaid, A. (2023 May 16-19) Full body embolic protection during transcatheter aortic valve replacement: Emboliner Embolic Protection Device, Clinical Highlights. euroPCR 2023 Paris, France.

May 9, 2023- PRESS RELEASE

Emboline Announces First Patient Treated in IDE Study of Emboliner® Full-Body Embolic Protection Catheter to Minimize Stroke Risk From TAVR